Pulmatrix Inc. is a clinical stage biotechnology company, which engages in the discovery and development of novel inhaled therapeutic products for respiratory and other diseases. The firm focuses on the prevention and treatment of respiratory diseases and infections. It offers products based on its proprietary dry powder delivery technology, iSPERSE, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications.
Looking for breakout of blue line. This could be a major player in administering any medicine that needs to get to the lungs. Awfully quiet right now...could change soon.
Looking for breakout of blue line. This could be a major player in administering any medicine that needs to get to the lungs. Awfully quiet right now...could change soon.